Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Mouse models of tau variants linked to neurodegenerative disease

Technology #2020-123

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Collections
Image Gallery
Mouse model to study the role P301L Tau mutant protein in neurodegenerative disease.
Categories
Researchers
Michael Koob, PhD
Associate Professor, Department of Laboratory Medicine and Pathology
External Link (med.umn.edu)
Kellie Benzow, PhD
Scientist, Department of Laboratory Medicine and Pathology
Managed By
Kenneth Karanja
Technology Licensing Officer 612-624-4531
Publications
Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Nature Communications, 10, Article number: 2479 (2019)
An improved and controlled mouse model expressing human tau P301L protein, a common mutation linked to neurodegeneration.

A carefully crafted mouse model of neurodegeneration

The vast majority of therapies found to be effective in mouse models of neurodegeneration fail in humans. This failure to translate highlights the need to ensure that transgenic animal models are created with intense attention to detail to increase relevance and understanding of the associated limitations. Mutation P301L in the protein tau (encoded by the MAPT gene) is a common mutation linked to neurodegeneration and represents an important area of focus. The mouse model currently used to study this mutation (rTg4510), has a 70-copy tau-transgene insertion in a 244 kb deletion of another gene (Fgf14). These additional genomic changes confound the observed-phenotypes which may or may not be due to the P301L mutation of interest. The lab of Dr. Michael Koob at the University of Minnesota has carefully developed a cleaner mouse model for the purpose of studying the role of the Tau P301L mutant in neurodegeneration. This transgenic mouse includes a single targeted MAPT cDNA insertion that expresses tauP301L (T2 mouse).

Phase of Development

MAPT T2 mice have been generated, characterized and published.

Ready for Licensing

This technology is now available for license! The University is excited to partner with industry to see this innovation reach its potential. Please contact Kenneth Karanja to share your business’ needs and your licensing interests in this technology.